Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Therion's Prostvac vaccine shows promise in phase I prostate cancer study

May 15, 2000

Important drug warning issued for Herceptin

May 12, 2000

Patients with ovarian cancer sought for phase III trial

May 11, 2000

Multikine shows promising efficacy and safety in phase II trial

May 11, 2000

FDA grants fast track status to Biomira's breast cancer vaccine

May 10, 2000

Maxamine plus IL-2 improves survival in late-stage malignant melanoma

May 4, 2000

Neurocrine Biosciences obtains orphan drug status for glioblastoma therapy

May 2, 2000

Neurocrine Biosciences reports positive results from phase I/II malignant glioma trial

April 27, 2000

Campath MAA accepted for review by European authorities

April 26, 2000

Novelos Therapeutics initiates first U.S. trial of BAM-002

April 25, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...